Xiaoxiang Tian

Title: The Innovative Contributions of Xiaoxiang Tian

Introduction

Xiaoxiang Tian is a notable inventor based in Shenyang, China. He has made significant contributions to the field of medicine, particularly in the area of cardiac health. His work focuses on the medical applications of specific proteins that can aid in the treatment of serious heart conditions.

Latest Patents

Xiaoxiang Tian holds a patent for the medical use of Cellular Repressor of E1A-stimulated Genes (CREG) protein. This invention relates to the use of CREG protein or its active fragments in the manufacture of medicaments aimed at preventing and treating myocardial infarction. Additionally, it addresses ventricular remodeling after myocardial infarction and heart failure, as well as myocardial ischemia-reperfusion injury and salt-sensitive hypertensive myocardial fibrosis. He has 1 patent to his name.

Career Highlights

Xiaoxiang Tian is affiliated with the General Hospital of Chinese PLA Northern Theater Command. His role in this esteemed institution allows him to contribute to groundbreaking research and development in medical science. His work is crucial in advancing treatment options for patients suffering from heart-related ailments.

Collaborations

Xiaoxiang Tian collaborates with esteemed colleagues such as Yaling Han and Chenghui Yan. Their combined expertise enhances the research and development efforts within their institution.

Conclusion

Xiaoxiang Tian's innovative work in the medical field, particularly regarding the CREG protein, showcases his commitment to improving cardiac health. His contributions are vital for the advancement of treatments for serious heart conditions.